Arkolith/Insider Trading/RPHM/Form 4

Jindal Vineet R.

Chief Financial OfficerReneo Pharmaceuticals, Inc. (RPHM) · full profile →Form 4 · filed Aug 26, 2021
Net Buying
Open-Market Buys
$37K
Open-Market Sells
$0
Net Open-Market Flow
$37K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 25, 2021Buy(P)5K$7.44$37K5K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-21-053523) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML